Your browser doesn't support javascript.
loading
The tumor cell-secreted matricellular protein WISP1 drives pro-metastatic collagen linearization.
Jia, Hong; Janjanam, Jagadeesh; Wu, Sharon C; Wang, Ruishan; Pano, Glendin; Celestine, Marina; Martinot, Ophelie; Breeze-Jones, Hannah; Clayton, Georgia; Garcin, Cecile; Shirinifard, Abbas; Zaske, Ana Maria; Finkelstein, David; Labelle, Myriam.
Afiliação
  • Jia H; Department of Developmental Neurobiology, Comprehensive Cancer Center, Solid Tumor Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Janjanam J; Department of Developmental Neurobiology, Comprehensive Cancer Center, Solid Tumor Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Wu SC; Department of Developmental Neurobiology, Comprehensive Cancer Center, Solid Tumor Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Wang R; Department of Developmental Neurobiology, Comprehensive Cancer Center, Solid Tumor Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Pano G; Department of Developmental Neurobiology, Comprehensive Cancer Center, Solid Tumor Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Celestine M; Department of Developmental Neurobiology, Comprehensive Cancer Center, Solid Tumor Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Martinot O; Department of Developmental Neurobiology, Comprehensive Cancer Center, Solid Tumor Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Breeze-Jones H; Department of Developmental Neurobiology, Comprehensive Cancer Center, Solid Tumor Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Clayton G; Department of Developmental Neurobiology, Comprehensive Cancer Center, Solid Tumor Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Garcin C; Department of Developmental Neurobiology, Comprehensive Cancer Center, Solid Tumor Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Shirinifard A; Department of Developmental Neurobiology, Comprehensive Cancer Center, Solid Tumor Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Zaske AM; Division of Cardiology, Department of Internal Medicine, UTHealth - The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Finkelstein D; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Labelle M; Department of Developmental Neurobiology, Comprehensive Cancer Center, Solid Tumor Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
EMBO J ; 38(16): e101302, 2019 08 15.
Article em En | MEDLINE | ID: mdl-31294477
ABSTRACT
Collagen linearization is a hallmark of aggressive tumors and a key pathogenic event that promotes cancer cell invasion and metastasis. Cell-generated mechanical tension has been proposed to contribute to collagen linearization in tumors, but it is unknown whether other mechanisms play prominent roles in this process. Here, we show that the secretome of cancer cells is by itself able to induce collagen linearization independently of cell-generated mechanical forces. Among the tumor cell-secreted factors, we find a key role in this process for the matricellular protein WISP1 (CCN4). Specifically, WISP1 directly binds to type I collagen to promote its linearization in vitro (in the absence of cells) and in vivo in tumors. Consequently, WISP1-induced type I collagen linearization facilitates tumor cell invasion and promotes spontaneous breast cancer metastasis, without significantly affecting gene expression. Furthermore, higher WISP1 expression in tumors from cancer patients correlates with faster progression to metastatic disease and poor prognosis. Altogether, these findings reveal a conceptually novel mechanism whereby pro-metastatic collagen linearization critically depends on a cancer cell-secreted factor.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteínas Proto-Oncogênicas / Colágeno Tipo I / Proteínas de Sinalização Intercelular CCN Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: EMBO J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteínas Proto-Oncogênicas / Colágeno Tipo I / Proteínas de Sinalização Intercelular CCN Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: EMBO J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos